Pura Vida Investments, LLC Gilead Sciences, Inc. Call Options Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $11.3 Million - $12.9 Million	200,000 New	200,000 $11.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $3.98 Million - $4.62 Million	-55,000 Closed	0 $0
Q1 2020 Feb 12, 2021	BUY	$62.63 - $80.22 $3.41 Million - $4.37 Million	54,450 Added 9900.0%	55,000 $4.11 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $34,446 - $44,121	550 New	550 $241,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.